Transcriptome‐wide association study of breast cancer risk by estrogen‐receptor status

dc.contributor.authorFeng, Helian
dc.contributor.authorGusev, Alexander
dc.contributor.authorPasaniuc, Bogdan
dc.contributor.authorLázaro García, Conxi
dc.contributor.authorTeulé-Vega, Àlex
dc.contributor.authorGEMO Study Collaborators
dc.contributor.authorEMBRACE Collaborators
dc.contributor.authorGC‐HBOC Study Collaborators
dc.contributor.authorABCTB Investigators
dc.contributor.authorHEBON Investigators
dc.contributor.authorBCFR Investigators
dc.contributor.authorOCGN Investigators
dc.date.accessioned2021-02-26T08:01:30Z
dc.date.available2021-02-26T08:01:30Z
dc.date.issued2020-03-01
dc.date.updated2021-02-16T13:15:50Z
dc.description.abstractPrevious transcriptome-wide association studies (TWAS) have identified breast cancer risk genes by integrating data from expression quantitative loci and genome-wide association studies (GWAS), but analyses of breast cancer subtype-specific associations have been limited. In this study, we conducted a TWAS using gene expression data from GTEx and summary statistics from the hitherto largest GWAS meta-analysis conducted for breast cancer overall, and by estrogen receptor subtypes (ER+ and ER-). We further compared associations with ER+ and ER- subtypes, using a case-only TWAS approach. We also conducted multigene conditional analyses in regions with multiple TWAS associations. Two genes, STXBP4 and HIST2H2BA, were specifically associated with ER+ but not with ER- breast cancer. We further identified 30 TWAS-significant genes associated with overall breast cancer risk, including four that were not identified in previous studies. Conditional analyses identified single independent breast-cancer gene in three of six regions harboring multiple TWAS-significant genes. Our study provides new information on breast cancer genetics and biology, particularly about genomic differences between ER+ and ER- breast cancer.
dc.format.extent27 p.
dc.format.mimetypeapplication/pdf
dc.identifier.pmid32115800
dc.identifier.urihttps://hdl.handle.net/2445/174394
dc.language.isoeng
dc.publisherWiley
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1002/gepi.22288
dc.relation.ispartofGenetic Epidemiology, 2020, vol. 44, num. 5, p. 442-468
dc.relation.projectIDinfo:eu-repo/grantAgreement/EC/H2020/669026/EU//BIORISE
dc.relation.projectIDinfo:eu-repo/grantAgreement/EC/H2020/633784/EU//B-CAST
dc.relation.projectIDinfo:eu-repo/grantAgreement/EC/FP7/223175/EU//COGS
dc.relation.projectIDinfo:eu-repo/grantAgreement/EC/H2020/634935/EU//BRIDGES
dc.relation.urihttps://doi.org/10.1002/gepi.22288
dc.rightscc by (c) Feng et al., 2020
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.sourceArticles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))
dc.subject.classificationCàncer de mama
dc.subject.classificationEstrògens
dc.subject.otherBreast cancer
dc.subject.otherEstrogen
dc.titleTranscriptome‐wide association study of breast cancer risk by estrogen‐receptor status
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
gepi.22288.pdf
Mida:
2.44 MB
Format:
Adobe Portable Document Format